share_log

EF Hutton Reiterates Buy on Coya Therapeutics, Maintains $28 Price Target

Benzinga ·  Jun 7, 2023 13:45

EF Hutton analyst Elemer Piros reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment